D. Beattie et al. / Bioorg. Med. Chem. Lett. 22 (2012) 6280–6285
6285
Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis,
Management, and Prevention of Chronic Obstructive Pulmonary Disease.
13. Stocks, M. J.; Alcaraz, L.; Bailey, A.; Bonnert, R.; Cadogan, E.; Christie, J.;
Connolly, S.; Cook, A.; Fisher, A.; Flaherty, A.; Hill, S.; Humphries, A.; Ingall, A.;
Jordan, S.; Lawson, M.; Mullen, A.; Nicholls, D.; Paine, S.; Pairaudeau, G.; St-
Gallay, S.; Young, A. Bioorg. Med. Chem. Lett. 2011, 21, 4027.
14. Wieland, K.; Zuurmond, H. M.; Krasel, C.; IJzerman, A. P.; Lohse, M. J. Proc. Natl.
Acad. Sci. USA 1996, 93, 9276.
Updated
2007.
Available
at:
2. Busse, W. W.; Shah, S. R.; Somerville, L.; Parasuraman, B.; Martin, P.; Goldman,
M. J. Allergy Clin. Immunol. 2008, 121, 1407.
3. Jacobsen, J. R. Future Med. Chem. 2011, 3, 1607.
15. Swaminath, G.; Xiang, Y.; Weon Lee, T.; Steenhuis, J.; Parnot, C.; Kobilka, B. K. J.
Bio. Chem 2004, 279, 686.
4. Tashkin, D. P. Expert Opin. Pharmacother. 2010, 11, 2077.
16. Beattie, D.; Bradley, M.; Brearley, A.; Charlton, S. J.; Cuenoud, B. M.; Fairhurst, R.
A.; Gedeck, P.; Gosling, M.; Janus, D.; Jones, D.; Lewis, C.; McCarthy, C.;
Oakman, H.; Stringer, R.; Taylor, R. J.; Tuffnell, A. Bioorg. Med. Chem. Lett. 2010,
20, 5302.
17. Farnum, D. G.; Carlson, G. R. Synthesis 1972, 191.
18. Prashad, M.; Hu, B.; Har, D.; Repic, O.; Blacklock, T. J.; Lohse, O. Org. Process Res.
Dev. 2006, 10, 135.
19. Battram, C.; Charlton, S. J.; Cuenoud, B.; Dowling, M. R.; Fairhurst, R. A.; Farr, D.;
Fozard, J. R.; Leighton-Davies, J. R.; Lewis, C. A.; McEvoy, L.; Turner, R. J.;
Trifilieff, A. J. Pharmacol. Exp. Ther. 2006, 371, 762.
5. (a) Dixon, R. A. F.; Kobilka, B. K.; Strader, D. J.; Benovic, J. L.; Dohlman, H. G.;
Frielle, T.; Bolanowski, M. A.; Bennett, C. D.; Rands, E.; Diehl, R. E.; Mumford, R.
A.; Slater, E. A.; Sigal, I. S.; Caron, M. G.; Lefkowitz, R. J.; Strader, C. D. Nature
1986, 321, 75; (b) Rasmussen, S. G.; Choi, H.-E.; Rosenbaum, D. M.; Kobilka, T.
S.; Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R. P.; Sanishvili, R.;
Fischetti, R. F.; Schertler, G. F. X.; Weis, W. I.; Kobilka, B. K. Nature 2007, 450,
383.
6. Waldeck, B. Eur. J. Phamacol. 2002, 445, 1.
7. (a) Yoshizak, S.; Yo, E.; Otsubo, J. Chem. Parm. Bull. 1978, 26, 1611; (b) Yoshizak,
S.; Tamada, S.; Yo, E.; Umezato, M. Chem. Parm. Bull. 1993, 41, 1305.
8. Baur, F.; Beattie, D.; Beer, D.; Bentley, D.; Bradley, M.; Bruce, I.; Charlton, S. J.;
Cuenoud, B.; Ernst, R.; Fairhurst, R. A.; Faller, B.; Farr, D.; Keller, T.; Fozard, J.;
Fullerton, J.; Garman, S.; Hatto, J.; Hayden, C.; He, H.; Howes, C.; Janus, D.; Jiang,
Z.; Lewis, C.; Loeuillet-Ritzler, F.; Moser, H.; Reilly, J.; Alan Steward, A.; Sykes,
D.; Tedaldi, L.; Trifilieff, A.; Tweed, M.; Watson, S.; Wissler, E.; Wyss, D. J. Med.
Chem. 2010, 53, 3675.
20. Baker, J. G. Br. J. Pharmacol. 2010, 1048, 160.
21. Alikhani, V.; Beer, D.; Bentley, D.; Bruce, I.; Cuenoud, B. M.; Fairhurst, R. A.;
Gedeck, P.; Haberthuer, S.; Hayden, C.; Janus, D.; Jordan, L.; Lewis, C.; Smithies,
K.; Wissler, E. Bioorg. Med. Chem. Lett. 2004, 14, 4705.
22. Agonism was determined by the ability of test compounds to increase GTP
binding to membranes derived from Chinese Hamster Ovary cells expressing
the human dopamine D2 receptor. scintillation proximity assay with
GTP
35S was used as the readout. Intrinsic efficacy was based upon the
cS
A
9. Wang, T-C.; Chen, Y-L.; Lee, K-H.; Tzeng, C-C. Synthesis 1997, 87.
10. Srivastava, S. K.; Chauhan, P. M. S.; Bhaduri, A. P. Chem. Commun. 1996, 2679.
c
relative maximal responce compard to dopamine.
11. Preparative reversed phase chromatography was carried out using:
Phenomenex Luna C18 10
a
23. Rosethorne, E. M.; Turner, R. J.; Fairhurst, R. A.; Charlton, S. J. Naunyn-
Schmiedeberg’s Arch. Pharmacol. 2010, 382, 255.
24. Hoenke, C.; Bouyssou, T.; Tautermann, C. S.; Rudolf, K.; Schnapp, A.; Konetzki, I.
Bioorg. Med. Chem. Lett. 2009, 19, 6640.
25. Rasmussen, S. G. F.; Choi, H-J; Fung, J. J.; Pardon, E.; Casarosa, P.; Chae, P. S.;
DeVree, B. T.; Rosenbaum, D. M.; Thian, T. S.; Kobilka, T. S.; Schnapp, A.;
Konetzki, A.; Sunahara, R. K.; Gellman, S. H.; Pautsch, A.; Steyaert, J.; Weis, W.
I.; Kobilka, B. K. Nature 2011, 469, 175.
l
M column, 150 Â 50 mm; eluing with a gradient
from 10% to 95% acetonitrile in water containing 0.1% trifluoroacetic acid; with
UV detection at 254 nM. Final products were obtained either: as
trifluoroacetate salts by direct evaporation; or as free bases by partial
evaporation, to remove organics, netralisation with NaHCO3, and extraction
into ethyl acetate.
12. Bonnert, R. V.; Brown, R. C.; Chapman, D.; Cheshire, D. R.; Dixon, J.; Ince, F.;
Kinchin, E. C.; Lyons, A. J.; Davis, A. M.; Hallam, C.; Harper, S. T.; Unitt, J. F.;
Dougall, I. G.; Jackson, D. M.; McKechnie, K.; Young, A.; Simpson, W. T. J. Med.
Chem. 1998, 41, 4915.
26. Sykes, D. A.; Charlton, S. J. Br. J. Pharmacol. 2012, 165, 2672.